Patent Law

Teva Intends to File Lawsuit Against Generic Filer for Patent Infringement
The following is excerpted from a July 11, 2008 Teva press release appearing at PharmaLive: Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today commented on Momenta Pharmaceuticals, Inc...

Teva Gets a Taste of Its Own Medicine
This from Brian Orelli, writing for The Motley Fool, on July 14, 2008: Now Teva Pharmaceutical (Nasdaq: TEVA) knows what it feels like to be on the other side of a patent challenge...

After Court Victory over FDA, Teva Receives Final Approval of Risperidone ANDA and Launches With 180-Day Exclusivity
Teva announced yesterday that the FDA granted final approval to its ANDA for generic Risperdal (risperidone) tablets, that it was awarded 180-day exclusivity as the first paragraph IV filer for risperidone, and that it immediately commenced a commercial launch...

Teva Seeks Relisting of J&J's Risperdal Patent and Asserts Right to 180-Day Exclusivity
A reader recently e-mailed me about an interesting citizen petition that Teva filed last August. In the petition, Teva requests that FDA: (1) relist U.S. Patent No. 5,158,952 in the Orange Book for Risperdal (risperidone) tablets; (2) confirm Teva's right...

No Inequitable Conduct if Examiner Finds Withheld Reference while Searching
Teva Pharm. Indus. v. Apotex, 2008 U.S. Dist. LEXIS 60418 (D.N.J. 2008) In 2007, Teva sued Apotex infringing its carvedilol patents. Apotex counterclaimed with charges of inequitable conduct ? alleging that Teva had failed to disclose "any of the English...

BU Economics Professor Releases Report on the Impact of Marketing Exclusivity on Biologics Innovation
By Donald Zuhn -- On Wednesday, Dr. Laurence J. Kotlikoff, a professor of economics at Boston University, released the results of his analysis of the impact of varying lengths of market exclusivity on innovation in the biotechnology sector....

Vytorin Marketing
alleged false claims in marketing campaign.

Teva Animal Health Expands Ketamine Hydrochloride Recall
Teva Animal Health Expands Ketamine Hydrochloride Recall

Poling Family Receives $1.5 Million in First Autism Vaccine Settlement
Poling Family Receives $1.5 Million in Autism Vaccine Settlement

Sprint
Receives Preliminary Approval of $17.5 Settlement for Early Termination Fees

Hazing Death
Phoummarath Family Receives $4.2 Million Settlement

Forest Laboratories Potentially Illegal Marketing
Forest Laboratories Potentially Illegal Marketing